{"title":"面肩肱肌营养不良症:遗传学和试验","authors":"Robin Warner","doi":"10.5772/intechopen.92672","DOIUrl":null,"url":null,"abstract":"A complex combination of molecular pathways and cell interactions causes facioscapulohumeral muscular dystrophy (FSHD). Several new therapies pose a promising solution to this disease with no cure. This chapter aims to explain the genetics of facioscapulohumeral muscular dystrophy, and review the current clinical trials for the treatment of FSHD.","PeriodicalId":359431,"journal":{"name":"Muscular Dystrophy - Research Updates and Therapeutic Strategies","volume":"65 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Facioscapulohumeral Muscular Dystrophy: Genetics and Trials\",\"authors\":\"Robin Warner\",\"doi\":\"10.5772/intechopen.92672\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A complex combination of molecular pathways and cell interactions causes facioscapulohumeral muscular dystrophy (FSHD). Several new therapies pose a promising solution to this disease with no cure. This chapter aims to explain the genetics of facioscapulohumeral muscular dystrophy, and review the current clinical trials for the treatment of FSHD.\",\"PeriodicalId\":359431,\"journal\":{\"name\":\"Muscular Dystrophy - Research Updates and Therapeutic Strategies\",\"volume\":\"65 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Muscular Dystrophy - Research Updates and Therapeutic Strategies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5772/intechopen.92672\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Muscular Dystrophy - Research Updates and Therapeutic Strategies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/intechopen.92672","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Facioscapulohumeral Muscular Dystrophy: Genetics and Trials
A complex combination of molecular pathways and cell interactions causes facioscapulohumeral muscular dystrophy (FSHD). Several new therapies pose a promising solution to this disease with no cure. This chapter aims to explain the genetics of facioscapulohumeral muscular dystrophy, and review the current clinical trials for the treatment of FSHD.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
